Terry Smith
Fundsmith
Terry Smith Medpace Holdings Inc stake
total: 91
Fundsmith MEDP trades
- Total transactions:
- 4
- New positions:
- 1
- Reduced:
- 3
- Held since:
- 2024 Q4
- Held for:
- 7 quarters
- Latest activity:
- 2026 Q2
According to 2026 Q2 report, Terry Smith holds 52,372 Medpace Holdings Inc (MEDP) shares with a market value of roughly $27.74M accounting for 0.20% of the overall portfolio. To date, the estimated cost basis is nearly $332.23 for "buy" trades and estimated average "sell" price is $535.69. Fundsmith first purchased MEDP in 2024 Q4, initially acquiring 127,537 shares. Since the initial investment in Medpace Holdings Inc (MEDP), Fundsmith has made 3 more transactions.
When did Terry Smith buy Medpace Holdings Inc (MEDP)?
Terry Smith first invested in Medpace Holdings Inc (MEDP) in 2024 Q4 at the reported quarter-end price of $332.23 per share.
What's the cost basis of Fundsmith's MEDP stake?
The estimated cost basis for Medpace Holdings Inc (MEDP) stake is around $332.23 per share. This represents their average reported price* across all buy transactions
Estimated cost basis*
- Weighted AVG buy price:
- $332.23
- Weighted AVG sell price:
- $535.69
Terry Smith's historical trades in Medpace Holdings Inc
4 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2026 Q2
|
0.20%
|
52,372
|
$529.59
|
$27,735,687
|
-16.43% (-10,296)
|
-0.04%
|
|
2026 Q1
|
0.23%
|
62,668
|
$480.19
|
$30,092,547
|
-24.10% (-19,899)
|
-0.06%
|
|
2025 Q4
|
0.27%
|
82,567
|
$561.65
|
$46,373,756
|
-35.26% (-44,970)
|
-0.13%
|
|
2024 Q4
|
0.18%
|
127,537
|
$332.23
|
$42,371,618
|
new
|
+0.18%
|
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.